FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $328,000 | -58.9% | 8,697 | -81.3% | 0.37% | +24.1% |
| Q1 2018 | $799,000 | -17.5% | 46,500 | +5.3% | 0.30% | -19.0% |
| Q4 2017 | $968,000 | +136.7% | 44,176 | +341.8% | 0.37% | +152.7% |
| Q3 2017 | $409,000 | -58.6% | 10,000 | -69.6% | 0.15% | -68.6% |
| Q2 2017 | $989,000 | +0.6% | 32,851 | +20.8% | 0.46% | +5.4% |
| Q1 2017 | $983,000 | +167.8% | 27,200 | +288.6% | 0.44% | +91.7% |
| Q3 2016 | $367,000 | -65.9% | 7,000 | -73.1% | 0.23% | -60.2% |
| Q2 2016 | $1,075,000 | -0.2% | 26,000 | -1.9% | 0.58% | +84.1% |
| Q1 2016 | $1,077,000 | +40.2% | 26,500 | +43.2% | 0.31% | +20.3% |
| Q4 2015 | $768,000 | -51.3% | 18,500 | -82.0% | 0.26% | -61.3% |
| Q3 2015 | $1,577,000 | +54.9% | 102,500 | +150.0% | 0.68% | +47.1% |
| Q2 2015 | $1,018,000 | +196.8% | 41,000 | +173.3% | 0.46% | +142.9% |
| Q1 2015 | $343,000 | – | 15,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 115,500 | $2,531,000 | 0.89% |
| AWM Investment Company, Inc. | 150,000 | $3,288,000 | 0.64% |
| BB BIOTECH AG | 827,500 | $18,139,000 | 0.51% |
| Virtus ETF Advisers LLC | 17,371 | $381,000 | 0.48% |
| Rock Springs Capital Management LP | 425,000 | $9,316,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,728 | $9,880,000 | 0.39% |
| Telemetry Investments, L.L.C. | 44,176 | $968,000 | 0.37% |
| RTW INVESTMENTS, LP | 100,377 | $2,200,000 | 0.37% |
| Eventide Asset Management | 315,000 | $6,905,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 52,500 | $1,151,000 | 0.22% |